An authorized generic of Plendil was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (felodipine) is available.
Source: FDA, updated October 30, 2026
Generic name: felodipine
Used for: High blood pressure
From
$12.49 for 30 tablets delivered ($7.24 plus $5.25 shipping)
Generic felodipine from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.
Need it today? From $13.33 for 30 tablets at Walgreens with the free Optum Perks coupon. Show the free coupon there. It can’t be used with insurance.
Get the free Optum Perks couponA regular generic has the same active ingredient as Plendil, and the FDA requires it to work the same way.
Details for each option
Plendil itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
An authorized generic of Plendil was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (felodipine) is available.
Source: FDA, updated October 30, 2026
Pharmacies’ own cash prices for generic felodipine, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
8 companies sell a generic of Plendil that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has lactose · Has a dye: D&C Yellow No. 10
Product page on avetpharma.com
2.5 mg Yellow, round, 11 mm, marked “I31”
| Package | NDC |
|---|---|
| Bottle of 100 | 23155-048-01 |
5 mg Light yellow, round, 11 mm, marked “I32”
| Package | NDC |
|---|---|
| Bottle of 100 | 23155-049-01 |
10 mg White, round, 11 mm, marked “I33”
| Package | NDC |
|---|---|
| Bottle of 100 | 23155-050-01 |
Inactive ingredients: polyoxyl 40 hydrogenated castor oil, magnesium aluminum silicate, hypromellose 2208 (15000 mpa.s), lactose monohydrate, hydroxypropyl cellulose (1600000 wamw), sodium stearyl fumarate, hypromellose 2910 (5 mpa.s), titanium dioxide, polyethylene glycol 400, ferric oxide yellow, D&C Yellow No. 10
Has lactose · Made by Yung Shin Pharmaceutical Industrial
2.5 mg White, round, 11 mm, marked “YSP / 211”
| Package | NDC |
|---|---|
| Bottle of 100 | 61442-431-01 |
| Bottle of 500 | 61442-431-05 |
5 mg Orange, round, 11 mm, marked “YSP / 210”
| Package | NDC |
|---|---|
| Bottle of 100 | 61442-432-01 |
| Bottle of 500 | 61442-432-05 |
10 mg Red, round, 11 mm, marked “YSP / 051”
| Package | NDC |
|---|---|
| Bottle of 100 | 61442-433-01 |
| Bottle of 500 | 61442-433-05 |
Inactive ingredients: lactose monohydrate, hydroxypropyl cellulose (110000 wamw), silicon dioxide, hypromellose 2208 (100 mpa.s), magnesium stearate, butylated hydroxyanisole, calcium phosphate, dibasic, anhydrous, polyethylene glycol 1000, titanium dioxide
Has lactose · Made by Pharmobedient Consulting
2.5 mg Yellow, round, 11 mm, marked “Y161”
| Package | NDC |
|---|---|
| Bottle of 90 | 62135-646-90 |
5 mg Pink, round, 11 mm, marked “Y162”
| Package | NDC |
|---|---|
| Bottle of 90 | 62135-647-90 |
10 mg Red, round, 11 mm, marked “Y163”
| Package | NDC |
|---|---|
| Bottle of 90 | 62135-648-90 |
Inactive ingredients: anhydrous lactose, butylated hydroxyanisole, butylated hydroxytoluene, silicon dioxide, hypromellose, polyoxyl 40 hydrogenated castor oil, microcrystalline cellulose, povidone k30, sodium stearyl fumarate, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, maltodextrin, medium-chain triglycerides, polydextrose, talc, titanium dioxide
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 2
Product page on glenmarkpharma-us.com
2.5 mg Green, round, 11 mm, marked “G19 / plain”
| Package | NDC |
|---|---|
| Bottle of 90 | 68462-233-90 |
| Bottle of 100 | 68462-233-01 |
| Carton of 100 | 68462-233-11 |
| Bottle of 1000 | 68462-233-10 |
5 mg Pink, round, 11 mm, marked “G19 / 5”
| Package | NDC |
|---|---|
| Bottle of 90 | 68462-234-90 |
| Bottle of 100 | 68462-234-01 |
| Carton of 100 | 68462-234-11 |
| Bottle of 1000 | 68462-234-10 |
10 mg Brown, round, 11 mm, marked “G19 / 10”
| Package | NDC |
|---|---|
| Bottle of 90 | 68462-235-90 |
| Bottle of 100 | 68462-235-01 |
| Carton of 100 | 68462-235-11 |
| Bottle of 1000 | 68462-235-10 |
Inactive ingredients: hydroxypropyl cellulose, hypromellose, kaolin, lactose monohydrate, microcrystalline cellulose, polyoxyl 40 hydrogenated castor oil, sodium stearyl fumarate, polyethylene glycol, titanium dioxide, D&C Yellow No. 10, FD&C Blue No. 2, ferric oxide yellow, ferric oxide red
Has lactose · Has a dye: FD&C Blue No. 2 · Made by PH Health
2.5 mg Green, round, 11 mm, marked “E136”
| Package | NDC |
|---|---|
| Bottle of 100 | 0603-3581-21 |
| Bottle of 500 | 0603-3581-28 |
5 mg Pink, round, 11 mm, marked “E137”
| Package | NDC |
|---|---|
| Bottle of 100 | 0603-3582-21 |
| Bottle of 500 | 0603-3582-28 |
10 mg Red, round, 11 mm, marked “E138”
| Package | NDC |
|---|---|
| Bottle of 100 | 0603-3583-21 |
| Bottle of 500 | 0603-3583-28 |
Inactive ingredients: calcium silicate, polyoxyl 40 castor oil, hydroxypropyl cellulose (1600000 wamw), hypromelloses, lactose form, cellulose, microcrystalline, propyl gallate, sodium stearyl fumarate, titanium dioxide, triacetin, FD&C Blue No. 2, ferric oxide yellow, ferric oxide red
Has lactose · Has a dye: FD&C Blue No. 2 · Made by Aurobindo Pharma
2.5 mg Green, round, 11 mm, marked “X / 15”
| Package | NDC |
|---|---|
| Bottle of 100 | 57237-108-01 |
5 mg Pink, round, 11 mm, marked “X / 16”
| Package | NDC |
|---|---|
| Bottle of 100 | 57237-109-01 |
10 mg Brown, round, 11 mm, marked “X / 17”
| Package | NDC |
|---|---|
| Bottle of 100 | 57237-110-01 |
Inactive ingredients: silicon dioxide, aluminum silicate, hydroxypropyl cellulose, hypromellose 2910 (50 mpa.s), hypromellose 2208 (100 mpa.s), hypromellose 2910 (6 mpa.s), lactose monohydrate, microcrystalline cellulose, polyethylene glycol 6000, polyoxyl 40 hydrogenated castor oil, propyl gallate, sodium stearyl fumarate, titanium dioxide, FD&C Blue No. 2, ferric oxide yellow, ferric oxide red
Has lactose · Has a dye: FD&C Blue No. 2
2.5 mg Green, round, 8 mm, marked “32 / 2 / 5”
| Package | NDC |
|---|---|
| Bottle of 30 | 13668-132-30 |
| Bottle of 90 | 13668-132-90 |
| Bottle of 100 | 13668-132-01 |
| Bottle of 500 | 13668-132-05 |
| Bottle of 1000 | 13668-132-10 |
5 mg Pink, round, 11 mm, marked “33 / 5”
| Package | NDC |
|---|---|
| Bottle of 30 | 13668-133-30 |
| Bottle of 90 | 13668-133-90 |
| Bottle of 100 | 13668-133-01 |
| Bottle of 500 | 13668-133-05 |
| Bottle of 1000 | 13668-133-10 |
10 mg Reddish Brown, round, 11 mm, marked “34 / 10”
| Package | NDC |
|---|---|
| Bottle of 30 | 13668-134-30 |
| Bottle of 90 | 13668-134-90 |
| Bottle of 100 | 13668-134-01 |
| Bottle of 500 | 13668-134-05 |
| Bottle of 1000 | 13668-134-10 |
Inactive ingredients: cellulose, microcrystalline, silicon dioxide, FD&C Blue No. 2, ferric oxide yellow, hydroxypropyl cellulose, hypromelloses, lactose, magnesium oxide, polyoxyl 40 hydrogenated castor oil, propyl gallate, propylene glycol, sodium stearyl fumarate, talc, titanium dioxide, ferric oxide red
Has lactose · Sold as Felopdipine · Made by Pharmobedient Consulting
2.5 mg Yellow, round, 11 mm, marked “Y161”
| Package | NDC |
|---|---|
| Bottle of 100 | 69367-264-01 |
5 mg Pink, round, 11 mm, marked “Y162”
| Package | NDC |
|---|---|
| Bottle of 100 | 69367-265-01 |
10 mg Red, round, 11 mm, marked “Y163”
| Package | NDC |
|---|---|
| Bottle of 100 | 69367-266-01 |
Inactive ingredients: anhydrous lactose, butylated hydroxyanisole, butylated hydroxytoluene, silicon dioxide, hypromellose, polyoxyl 40 hydrogenated castor oil, microcrystalline cellulose, povidone k30, sodium stearyl fumarate, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, maltodextrin, medium-chain triglycerides, polydextrose, talc, titanium dioxide
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Felodipine extended-release tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (eg, on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Felodipine extended-release tablets, USP may be administered with other antihypertensive agents.
Source: the FDA label for Felodipine (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.), August 11, 2026. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/plendil/